CBP officers at Progreso Port of Entry arrested a man wanted for sexual assault after a thorough biometric check.
VELA-1 and VELA-2 are two identical trials to evaluate the efficacy and safety of sonelokimab in adult participants with moderate to severe ...
Everyone is talking AI these days – and regulators are taking notice. The Artificial Intelligence Act (AI Act), recently adopted by the European Parliament, marks a significant regulatory step in the ...
Background/aim Frequent premature ventricular complexes (PVCs) have historically been regarded as benign in structurally ...
Daiichi Sankyo & AstraZeneca’s sBLA for Enhertu followed by THP accepted in US for patients with high-risk HER2 positive early-stage breast cancer prior to surgery: Tokyo Friday ...
Background: Epicardial adipose tissue (EAT) promotes atrial remodeling, yet prospective data on whether a single transthoracic-echocardiographic measurement of EAT can identify elderly hypertensive ...
Investing.com -- aTyr Pharma (NASDAQ:ATYR) stock fell 80% after the company announced that its Phase 3 EFZO-FIT study of efzofitimod in pulmonary sarcoidosis failed to meet its primary endpoint. The ...
Microsoft is working to resolve a bug that causes Defender for Endpoint to incorrectly tag some devices' BIOS (Basic Input/Output System) firmware as outdated, prompting users to update it. Microsoft ...
The U.S. Cybersecurity and Infrastructure Security Agency (CISA) has published an analysis of the malware deployed in attacks exploiting vulnerabilities affecting Ivanti Endpoint Manager Mobile (EPMM) ...
ARLINGTON, Mass., Sept. 29, 2025 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative ...
CARMEL, Ind., Sept. 22, 2025 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide ...